August 2016 News
Scott Hefty (associate professor) is co-Investigator on an NIH Center for Biomedical Research Excellence (COBRE) project that was funded for $11 million. The grant, entitled “Chemical Biology of Infectious Disease”, is to enable University of Kansas researchers on the Lawrence campus to better contribute to the fight against infectious disease by studying fundamental biology with the use of small molecule chemical probes. Dr. Hefty’s role in the project is to serve as co-investigator for the COBRE and to lead the establishment of an Infectious Disease Assay Development (IDAD) Core to provide expertise, facilities, services, and training in the area of HTS assay design, development, validation, small and large-scale screening for organism (cell) based or biochemical infectious disease targets. Thomas Prisinzano, professor and chair of the Department of Medicinal Chemistry is the Principal Investigator of the grant.
Kristi Neufeld (associate professor) had an article from her laboratory entitled, “Human cancer xenografts in outbred nude mice can be confounded by polymorphisms in a modifier of tumorigenesis” recommended in F1000Prime as being of special significance in its field by F1000 Faculty Member Kent Hunter, Deputy Chief of the Laboratory of Cancer Biology and Genetics at the National Cancer Institute.
Audrey Lamb (professor) served as co-chair of the Enzymes, Coenzyme and Metabolic Pathways Gordon Research Conference in Waterville Valley, New Hampshire, July 24-29.
Andy Wolfe (graduate student, Neufeld lab) was the recipient of Candlin and MB GSO travel awards to attend the FASEB conference Cell Signaling in Cancer: from Mechanisms to Therapy in Snowmass Village, CO, June 5-10 and present his poster entitled, “Suppression of intestinal tumorigenesis in Apc mutant mice by Musashi-1 deletion”. He also received the E. L. and Mildred Pursell Wolf Scholarship for summer tuition.